En estudios clnicos, demostr una reduccin de peso del 20% en un tercio de los pacientes, y del 17% como promedio general
Common symptoms include persistent nausea, early fullness after eating, vomiting undigested food hours later, abdominal pain, and unexplained weight loss
* Nota: La dosis inicial ms baja (0,25 mg/semana) est destinada a reducir los sntomas gastrointestinales adversos, pero no proporciona un control glucmico eficaz
Next-generation selective JAK1 and TYK2 inhibitors aim to preserve efficacy while mitigating safety concerns through enhanced selectivity
This guide provides a comprehensive overview of subq medication administration, including anatomical sites for injection, appropriate needle size and angle, and clinical tips for administering specific medications